Secondary Lymphedema
in Lymphedema
Applied
Type
ModificationConfidence
90%
Created
Mar 26, 2026
Evidence
3 sources
Rationale
The section was updated to incorporate the latest high-level evidence (meta-analyses and systematic reviews) regarding breast cancer-related lymphedema (BCRL). Specifically, the text now details the types of early interventions that reduce incidence and the specific socioeconomic factors that create barriers to care. The role of physical therapy was also reinforced using the findings of a network meta-analysis. Abbreviations were expanded on first use as required.
Evidence
Content Changes
removedadded
<!-- type: risk-factors --> * **Cancer-related:** most common cause in developed countries. + Breast cancer-related lymphedema (BCRL) (axillary lymph node dissection, radiation); early preventive interventionsinterventions, including prospective surveillance and early compression therapy, are critical in reducing incidence [@wu2026].[@wu2026-effects]. + Gynecologic malignancies (pelvic node dissection). + Prostate and urologic cancers. + Socioeconomic disparities and barriers to carecare, such as race and insurance status, significantly influence the prevalence and severity of BCRL [@mattia2025].[@mattia2025-disparities]. * **Infectious:** + Filariasis (*Wuchereria bancrofti*) – leading global cause. * **Other:** + Trauma, chronic venous insufficiency (CVI) (see [[CVI]]), obesity, inflammatory conditions. + Physical therapy remains a primary intervention for managing secondary lymphedema associated with breast cancercancer, [@which2025].with network meta-analyses confirming its effectiveness in reducing limb volume [@which2025-which].